Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
16 p, 1.2 MB Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers / Chereau, Fanny (Université Paris-Saclay) ; Madec, Yoann (Institut Pasteur) ; Sabin, Caroline A (Research Department of Infection and Population Health (Regne Unit)) ; Obel, Niels (Copenhagen University Hospital Rigshospitalet) ; Ruiz-Mateos, Ezequiel (Instituto de Biomedicina de Sevilla) ; Chrysos, Georgios (Tzaneio General Hospital of Piraeus) ; Fidler, Sarah (Imperial College (Regne Unit)) ; Lehmann, Clara (University of Cologne and German Center for Infection Research) ; Zangerle, Robert (DMedical University Innsbruck) ; Wittkop, Linda (University Bordeaux) ; Reiss, Peter (Stichting HIV Monitoring) ; Hamouda, Osamah (Robert Koch Institute) ; Estrada Perez, Vicente (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Leal, Manuel (Instituto de Biomedicina de Sevilla) ; Mocroft, Amanda (Research Department of Infection and Population Health (Regne Unit)) ; García de Olalla, Patricia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Ammassari, Adriana (Istituto Nazionale Malattie Infettive) ; D'Arminio Monforte, Antonella (University Hospital (Itàlia)) ; Mussini, Cristina (University of Modena and Reggio Emilia) ; Segura, Ferran (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Castagna, Antonella (San Raffaele Vita Salute University) ; Cavassini, Matthias (Lausanne University Hospital) ; Grabar, Sophie (Institut Pierre Louis d'Epidémiologie et de Santé Publique) ; Morlat, Philippe (Université de Bordeaux) ; De Wit, Stéphane (Université Libre de Bruxelles) ; Lambotte, Olivier (Université Paris Sud) ; Meyer, Laurence (Université Paris-Saclay) ; Universitat Autònoma de Barcelona
HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretroviral therapy (ART), a small number of whom will eventually lose this ability to control HIV viremia. [...]
2017 - 10.1371/journal.pone.0173893  
2.
7 p, 259.3 KB Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment : Collaborative Cohort Study / May, Margaret T. ; Vehreschild, Jorg-Janne ; Trickey, Adam ; Obel, Niels ; Reiss, Peter ; Bonnet, Fabrice ; Mary-Krause, Murielle ; Samji, Hasina ; Cavassini, Matthias ; Gill, Michael John ; Shepherd, Leah C. ; Crane, Heidi ; D'Arminio Monforte, Antonella ; Burkholder, Greer A. ; Johnson, Margaret M. ; Sobrino-Vegas, Paz ; Domingo, Pere (Domingo Pedrol) ; Zangerle, Robert (Universitat Autònoma de Barcelona. Departament de Medicina) ; Justice, Amy C. ; Sterling, Timothy R. ; Miró, José M. ; Sterne, Jonathan A. C.
The strong association of CD4 count at start of combination therapy with subsequent survival in HIV-infected patients diminished during the first 5 years of treatment. After 5 years, lower baseline CD4 counts were not associated with higher mortality. [...]
2016 - 10.1093/cid/ciw183
Clinical Infectious Diseases, Vol. 62 (march 2016) , p. 1571-1577  
3.
11 p, 354.4 KB Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART : a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing / Cozzi-Lepri, Alessandro (University College London) ; Noguera-Julian, Marc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Di Giallonardo, Francesca (University Hospital Zurich (Suïssa)) ; Schuurman, Rob (Department of Virology. University Medical Centre, Utrecht) ; Däumer, Martin (Institut für Immunologie und Genetik, Kaiserslautern, Germany) ; Aitken, Sue (Department of Virology. University Medical Centre, Utrecht) ; Ceccherini-Silberstein, Francesca (Department of Experimental Medicine and Surgery, University of Rome Tor Vergata) ; D'Arminio Monforte, Antonella (Clinic of Infectious Diseases, 'San Paolo' Hospital) ; Geretti, Anna Maria (Institute of Infection & Global Health, University of Liverpool) ; Booth, Clare L. (Department of Virology, Royal Free London NHS Foundation Trust) ; Kaiser, Rolf (Institute of Virology, University of Cologne) ; Michalik, Claudia (Competence Network for HIV/AIDS, Bochum, Germany) ; Jansen, Klaus (Competence Network for HIV/AIDS, Bochum, Germany) ; Masquelier, Bernard (Université Bordeaux 2) ; Bellecave, Pantxika (Université Bordeaux 2) ; Kouyos, Roger D. (University Hospital Zurich (Suïssa)) ; Castro, Erika (Centre Hospitalier Universitaire Vaudois (Lausanne, Suïssa). Service of Community Psychiatry) ; Furrer, Hansjakob (Bern University Hospital) ; Schultze, Anna (University College London) ; Günthard, Huldrych F. (University Hospital Zurich (Suïssa)) ; Brun-Vezinet, Francoise (Department of Virology, Bichat University Hospital, Paris) ; Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Metzner, Karin J. (University Hospital Zurich (Suïssa)) ; CHAIN Minority HIV-1 Variants Working Group
It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART. This Europe-wide case-control study included ART-naive subjects infected with drug-susceptible HIV-1 as revealed by population sequencing, who achieved virological suppression on first-line ART including one NNRTI. [...]
2014 - 10.1093/jac/dku426
Journal of antimicrobial chemotherapy, Vol. 70 (october 2014) , p. 930-940  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.